Wall Street analysts predict that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will report earnings of $0.62 per share for the current quarter, according to Zacks. Three analysts have made estimates for Acadia Healthcare’s earnings. The highest EPS estimate is $0.68 and the lowest is $0.58. Acadia Healthcare posted earnings per share of $0.54 in the same quarter last year, which indicates a positive year-over-year growth rate of 14.8%. The company is scheduled to issue its next quarterly earnings report on Tuesday, August 3rd.

On average, analysts expect that Acadia Healthcare will report full-year earnings of $2.39 per share for the current fiscal year, with EPS estimates ranging from $2.33 to $2.49. For the next fiscal year, analysts expect that the company will report earnings of $2.80 per share, with EPS estimates ranging from $2.57 to $3.25. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, April 28th. The company reported $0.47 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.02. Acadia Healthcare had a return on equity of 7.55% and a net margin of 3.19%.

Several research analysts have issued reports on the stock. Citigroup lifted their price target on shares of Acadia Healthcare from $65.00 to $73.00 in a research report on Monday. Deutsche Bank Aktiengesellschaft raised their price target on Acadia Healthcare from $55.00 to $62.00 and gave the stock a “hold” rating in a research note on Monday, April 19th. Raymond James raised their price target on Acadia Healthcare from $65.00 to $70.00 and gave the stock a “strong-buy” rating in a research note on Monday. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating and set a $65.00 price objective on the stock. in a research note on Monday, April 19th. Finally, Mizuho lifted their price target on Acadia Healthcare from $53.00 to $62.00 and gave the stock a “neutral” rating in a research report on Friday. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Hold” and a consensus target price of $57.75.

In other news, Director Reeve B. Waud sold 109,443 shares of Acadia Healthcare stock in a transaction on Friday, March 12th. The stock was sold at an average price of $59.12, for a total value of $6,470,270.16. Following the transaction, the director now owns 25,765 shares in the company, valued at approximately $1,523,226.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.60% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. Eudaimonia Partners LLC acquired a new position in Acadia Healthcare during the 3rd quarter worth approximately $92,000. Brinker Capital Investments LLC purchased a new stake in shares of Acadia Healthcare in the third quarter worth $794,000. Strs Ohio raised its position in shares of Acadia Healthcare by 17.2% in the third quarter. Strs Ohio now owns 26,699 shares of the company’s stock worth $787,000 after buying an additional 3,909 shares in the last quarter. Wedge Capital Management L L P NC purchased a new stake in Acadia Healthcare during the fourth quarter valued at about $331,000. Finally, First Citizens Bank & Trust Co. purchased a new stake in Acadia Healthcare during the fourth quarter valued at about $440,000.

NASDAQ:ACHC traded up $0.19 during midday trading on Tuesday, hitting $62.28. 311,041 shares of the stock were exchanged, compared to its average volume of 575,646. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $5.57 billion, a price-to-earnings ratio of 54.95, a P/E/G ratio of 1.49 and a beta of 1.49. Acadia Healthcare has a one year low of $23.01 and a one year high of $63.06. The business has a 50-day moving average price of $59.27 and a two-hundred day moving average price of $50.15.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.

Recommended Story: Retained Earnings

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.